Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

INCYTE CORP Director's Dealing 2025

Jan 8, 2025

30371_dirs_2025-01-08_18becb22-5cc9-4585-9ae9-fdeff6864aaa.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: INCYTE CORP (INCY)
CIK: 0000879169
Period of Report: 2025-01-06

Reporting Person: Issa Mohamed Khairie (EVP, Head of US Oncology)

More from INCYTE CORP

Major Shareholding Notification 2026
May 14
Major Shareholding Notification 2026
May 11
Major Shareholding Notification 2026
Apr 30
Annual Report 2026
Apr 28
Proxy Solicitation & Information Statement 2026
Apr 28
Proxy Solicitation & Information Statement 2026
Apr 28
Interim / Quarterly Report 2026
Apr 28
Regulatory Filings 2026
Apr 28
Regulatory Filings 2026
Mar 30
Major Shareholding Notification 2026
Mar 27
View all filings →